Antihemophilic Factor (Recombinant [Porcine Sequence]) and Oritavancin
Determining the interaction of Antihemophilic Factor (Recombinant [Porcine Sequence]) and Oritavancin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Oritavancin Diphosphate
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Oritavancin Intravenous
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Orkambi
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Orkambi (Lumacaftor and Ivacaftor Granules)
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Orkambi (Lumacaftor and Ivacaftor Tablets)
- Antihemophilic Factor (Recombinant [Porcine Sequence])-Orlistat
- Oritavancin-Antihemophilic Factor (Recombinant) (Advate)
- Oritavancin-Antihemophilic Factor (Recombinant) (Afstyla)
- Oritavancin-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Oritavancin-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Oritavancin-Antihemophilic Factor (Recombinant) (Nuwiq)
- Oritavancin-Antihemophilic Factor (Recombinant) (Recombinate)